thedailyupside1h
Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough
Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the ...
New health care policy changes will soon affect weight-loss drugs
Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...
BioSpace9h
While Lilly Blames Wholesalers for Slow GLP-1 Sales, Novo’s Rival Medicine Is Flowing
Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.
Awkward moment Ben Shephard is forced to step in as Nadine Dorries ‘plugs weight loss drug supplier’ on This Morning
BEN Shephard awkwardly stepped in on today’s This Morning when former politician Nadine Dorries repeatedly plugged a ...
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
That means it aspires to directly compete with the likes of Eli Lilly and Novo Nordisk, the big pharmas that currently split the bulk of the market for weight loss drugs. Per new data it presented at ...
FDA adds new warning to weight loss drugs including Wegovy
GLP-1s — which can be prescribed for diabetes treatment or for weight loss management — have a few effects on the body. One ...
cnbctv1822h
Novo Nordisk's Wegovy weight-loss drug sales beat forecast, shares jump
Shares in Novo Nordisk which competes with Eli Lilly in an obesity drug market that some analysts forecast could be worth about $150 billion by the early 2030s, rose nearly 9%.